Ray Guidotti, Chief Operating Officer at Simtra BioPharma Solutions, talks about the company's strategic development and how it supports customers with a focus on excellence.
Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.
This paper reflects upon the past 15 years of experience in the application of QRM and KM within the pharmaceutical GMP environment.
We have proposed a comprehensive capping index parameter which is a ratio of compact anisotropic index to material anisotropic index. This study will help to design or select right tooling for successful tablet manufacturing.
The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
In order to combat the threat of counterfeits in Europe, the EU's current anti-counterfeiting directive is being amended.
Eradicating paper-based workflows and standalone solutions operating in isolation provides a good starting point to update quality management processes.
This tutorial paper is meant to aid in dielectric-sensor selection
While companies today outsource numerous processes, from early development through to manufacturing, there are still many opportunities to realize the full potential of outsourcing services.
The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.
Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.
Several steps need be taken to achieve lights-out, fully automated operations.
In this first of a four-part series, the authors provide an introduction to a practical approach for establishing specification equivalence. The regulatory basis and compliance examples from FDA observations and warning letters are included to support the need for an effective process.
Prior to use in a continuous manufacturing system for oral solid dosage forms, loss-in-weight feeders need to be tested and validated to understand the performance capabilities of a given material–feeder combination. In this article, the proper strategy for set-up and optimization of a loss-in-weight feeder is demonstrated for a range of materials. The optimized set-up of the feeders was demonstrated to provide suitable performance for even the most challenging, poorly flowing materials.
How can crystal engineering and pharma sciences be combined to enhance the clinical performance of drugs?
This article explores the emergence of subjectivity in ICH Q9 (R1).
This article provides an overview of the key risks that can be associated with the use of secondary reference standards (RS) and illustrates scientific challenges associated with transitioning from pharmacopeial RS to secondary RS.
For tech transfer of sterile injectables, vetting CMO partners means more than availability of facilities or the equipment, CMO partners should offer end-to-end support
Although vials and prefilled syringes have different advantages, both find use in vaccine fill/finish.
There are a number of validation approaches that can be adopted for single-use systems - all of which incorporate an established approach.
Both biosimilar and generic drugs have an abbreviated approval process; however, the clinical trial requirements differ enormously.
Using the four-phased method to assess QRM can ensure continual improvement and that regulatory requirements are met.
Once APIs move into later phases of development, an advanced impurity control strategy is vital and demands a comprehensive analytical methods approach.
Equipment qualification is a critical step in ensuring that a product or service is provided accurately and consistently with regards to manufacturing and testing. The time-saving attribute of adding prerequisites to a qualification program, along with the benefit of gaining the ability to track and trend problem areas, make the addition both worthwhile and cost-effective.
The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments.
Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines.
QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs.
QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs.
The authors evaluated the effect of polymer composition on the drug-release profile and the effect of storage conditions on dissolution characteristics.
Sufficient stability studies show a drug product meets regulatory requirements, therefore ensuring the drug reaches the patients who rely on it.